Loading clinical trials...
Loading clinical trials...
A Prospective Cross-Sectional and Longitudinal Study With Additional Retrospective Chart Review to Evaluate Clinical and Biochemical Characteristics and Disease Progression in Patients With Mucopolysaccharidosis Type IIIB
Conditions
Locations
7
United States
Minneapolis, Minnesota, United States
Pittsburgh, Pennsylvania, United States
Porto Alegre, Brazil
Monza, Italy
Coimbra, Portugal
Barcelona, Spain
Start Date
September 14, 2014
Primary Completion Date
July 11, 2017
Completion Date
July 11, 2017
Last Updated
September 13, 2018
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions